Clareon PanOptix Pro vs. Clareon PanOptix - Study B

Launched by ALCON RESEARCH · May 2, 2024

Keywords

ClinConnect Summary

This clinical trial, called Clareon PanOptix Pro vs. Clareon PanOptix - Study B, is looking at two types of lenses used in cataract surgery. Specifically, it compares the Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) to the Clareon™ PanOptix™ Trifocal IOL. The goal is to determine which lens is safer and more effective for patients who have lost their ability to focus clearly due to conditions like aphakia (a condition where the eye's natural lens is missing) and presbyopia (difficulty seeing close objects with age).

To be eligible for this study, participants must be planning to have cataract surgery on both eyes and should have a specific level of vision (with less than 1.00 diopter of astigmatism) in each eye. They also need to be able to attend all study visits and understand the study details. However, women who are pregnant, planning to become pregnant, or breastfeeding are not eligible, nor are those with certain eye conditions or who want a specific type of vision correction called monovision. Participants in this trial can expect to attend several visits to monitor their progress and results after receiving one of the lenses. This study is currently active but not recruiting new participants at this time.

Gender

ALL

Eligibility criteria

• Key Inclusion Criteria:
• • Understand and sign an ethics committee-approved informed consent form;
• • Willing and able to attend all scheduled study visits as required by the protocol;
• • Planned cataract surgery (both eyes);
• • Preoperative corneal astigmatism less that 1.00 diopter in each eye.
• • Other protocol-defined inclusion criteria may apply.
• Key Exclusion Criteria:
• • Women of childbearing potential if currently pregnant, intend to become pregnant during the study, or are breastfeeding;
• • Ocular conditions as specified in the protocol;
• • Subjects who desire monovision correction.
• • Other protocol-defined exclusion criteria may apply.